Global biosimilars market growth is driven by the increasing number of biosimilar approvals and the rising number of biologics coming off patent.
A biosimilar is a biological product that is similar to a reference biologic with no clinically meaningful differences in terms of potency, purity, and safety. The growth in the biosimilars market is driven by growing number of off-patent molecules, rising focus of key players on biosimilar development, and the cost benefits offered by biosimilars compared […]
Continue Reading